Baker Bros. Advisors’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
DTC
TCM
BC
FLAM
WP
GPP
Baker Bros. Advisors's ANAB Position: Q4 2023 in Review
Baker Bros. Advisors sold out of AnaptysBio (ANAB) in Q4 2023, closing a stake of 106,197 shares — an estimated $1.91M sold.
Baker Bros. Advisors first reported a position in ANAB in Q1 2017 and held it in 27 quarters. The position peaked at $24M in Q4 2022. 119 funds tracked by Wall St. Rank hold ANAB as of Q4 2023.
- Baker Bros. Advisors reported no remaining AnaptysBio position as of Q4 2023 after selling out during the quarter.
- Baker Bros. Advisors sold 106,197 AnaptysBio shares in Q4 2023, an estimated $1.91M.
- Baker Bros. Advisors first reported a position in AnaptysBio in Q1 2017 and held it in 27 quarters.
- Baker Bros. Advisors's AnaptysBio position peaked at $24M in Q4 2022.
- 119 funds tracked by Wall St. Rank held AnaptysBio as of Q4 2023.
Based on Baker Bros. Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.